These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 18227622)

  • 1. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
    Van Biervliet S; Vanbillemont G; Van Biervliet JP; Declercq D; Robberecht E; Christophe A
    Ann Nutr Metab; 2007; 51(6):541-9. PubMed ID: 18227622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
    Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
    J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.
    Strandvik B; Gronowitz E; Enlund F; Martinsson T; Wahlström J
    J Pediatr; 2001 Nov; 139(5):650-5. PubMed ID: 11713441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients.
    Van Biervliet S; Devos M; Delhaye T; Van Biervliet JP; Robberecht E; Christophe A
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):109-15. PubMed ID: 18276127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy.
    Aldámiz-Echevarría L; Prieto JA; Andrade F; Elorz J; Sojo A; Lage S; Sanjurjo P; Vázquez C; Rodríguez-Soriano J
    Pediatr Res; 2009 Nov; 66(5):585-9. PubMed ID: 19851226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
    Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial concordance of phenotype and microbial variation among siblings with CF.
    Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
    Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
    Preumont V; Hermans MP; Lebecque P; Buysschaert M
    Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype correlation for pulmonary function in cystic fibrosis.
    de Gracia J; Mata F; Alvarez A; Casals T; Gatner S; Vendrell M; de la Rosa D; Guarner L; Hermosilla E
    Thorax; 2005 Jul; 60(7):558-63. PubMed ID: 15994263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
    Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
    Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture.
    Caramia G; Cocchi M; Gagliardini R; Malavolta M; Mozzon M; Frega NG
    Pediatr Med Chir; 2003; 25(1):42-9. PubMed ID: 12920976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
    De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
    Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids.
    Keen C; Olin AC; Edentoft A; Gronowitz E; Strandvik B
    Chest; 2007 Jun; 131(6):1857-64. PubMed ID: 17400678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease.
    Van Biervliet S; Van Biervliet JP; Robberecht E; Christophe A
    Clin Chem Lab Med; 2010 Dec; 48(12):1751-5. PubMed ID: 20961201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
    Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
    Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
    Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
    J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease.
    Risé P; Volpi S; Colombo C; Padoan RF; D'Orazio C; Ghezzi S; Melotti P; Bennato V; Agostoni C; Assael BM; Galli C
    J Cyst Fibros; 2010 May; 9(3):228-33. PubMed ID: 20338832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
    Al-Turkmani MR; Freedman SD; Laposata M
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of deterioration of lung function in cystic fibrosis.
    Schaedel C; de Monestrol I; Hjelte L; Johannesson M; Kornfält R; Lindblad A; Strandvik B; Wahlgren L; Holmberg L
    Pediatr Pulmonol; 2002 Jun; 33(6):483-91. PubMed ID: 12001283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.